For Donors and Investors

For Donors and Investors cover image
FAST is deeply invested in bringing promising interventions into current medical practice, as safely and quickly as possible—and we know scientists are not the only ones who will make this happen.

To this end, FAST is driving translational research and supporting the advancement of therapeutics for animal models to humans living with Angelman syndrome. 

The goal is to advance as many promising therapeutic strategies as possible for Angelman syndrome, regardless of the obstacles, to find the best treatment options for our loved ones, for all ages and for all genotypes.

Supporting FAST’s mission can take many different forms.

Angelman Syndrome News